All patients n = 64 | SSO present n = 46 (72%) | SSO absent n = 18 (28%) | p-Value | |
---|---|---|---|---|
Baseline characteristics | ||||
Mean age (years) | 51 ± 20 | 51.4 ± 18 | 49.2 ±24 | 0.69 |
Male gender | 52 (81) | 37 (80) | 15 (83) | 0.30 |
Weight (kg) | 80 ± 11 | 81 ± 10 | 75 ± 12 | 0.047 |
Height (cm) | 175 ± 8 | 175 ± 8 | 176 (± 8 | 0.65 |
Body mass index(kg/m2) | 26 ± 3 | 27 ± 3 | 24 ± 3 | 0.006 |
Risk factors | ||||
Diabetes mellitus | 5 (7.8) | 5 (11) | 0 (0) | 0.145 |
Dyslipidaemia | 27 (42) | 21 (46) | 6 (34) | 0.37 |
Hypertension | 25 (39) | 20 (43) | 5 (28) | 0.247 |
Family history | 16 (25) | 12 (26) | 4 (23) | 0.748 |
Smoking | 21 (33) | 17 (37) | 4 (23) | 0.259 |
Medication | ||||
Aspirin | 24 (38) | 17 (37) | 7(39) | 0.886 |
Betablocker | 18 (28) | 15 (33) | 3 (17) | 0.202 |
ACE inhibitor | 24 (38) | 18 (39) | 6 (34) | 0.667 |
Statin | 27 (42) | 19 (41) | 8 (45) | 0.819 |
Medical history | ||||
Myocardial infarction | 10 (16) | 7 (15) | 3 (17) | 0.886 |
Stenting | 18 (28) | 13 (28) | 5 (28) | 0.969 |
CABG | 7 (11) | 4 (9) | 3 (170) | 0.358 |
13N-ammonia PET | ||||
Ischemia | 15 (23) | 9 (20) | 6 (34) | 0.242 |
Scar | 33 (52) | 22 (48) | 11 (61) | 0.1 |
Stress MBF (ml/min/g) | 2.12 ± 0.68 | 2.2 ± 0.66 | 1.93 ± 0.72 | 0.23 |
Rest MBF (ml/min/g) | 0.78 ± 0.26 | 0.77 ± 0.27 | 0.81 ± 0.24 | 0.65 |
MFR | 2.91 (± 1) | 3.07 ± 1.03 | 2.48 ± 0.96 | 0.038 |